Immunoprecise Antibodies Ltd IPA

IPA - revenue streams, services,...

[cleareye]

Sometimes I read comments here and wonder if I have confused stock symbols.

This company is not a biotech awaiting clinical trial results.

I think their revenue streams are intact.

They're going to be just fine. Recently some share holders were obviously sell, maybe shorting was taking place. Maybe that will continue. But the core business hasn't changed.

They describe themselves as:

ImmunoPrecise’s proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in ImmunoPrecise Antibodies, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery.

[wallpaper2]

Wrong...I was told by IR where they stood on Phase 1&2. I was told that there were 3 Phases and then trials. I was told we require lab space and a sugar daddy partner. You are on the wrong site.

[cleareye]

Hi wallpaper2, I was trying to express that IPA partners immediately with large pharma (and small).  They are a very different sort of company. They might announce a new partnership on another product tomorrow. They are not like a traditional biopharma startup which might have one or two products that they run through trials for 10 years with the hope of commercialization or a partnership at

[wallpaper2]

While collaborating on and developing other peoples needs, which is their CRO business,  they said they began focusing on their own research priorities. Which are the Covid virus cocktail and recently a Cancer cocktail. Results of their trials or tests on Covid infected hampsters with the original virus and the follow up trials on hampsters with the variants are in their Talem arm and

[cleareye]

Happy to let them run their business.

[wallpaper2]

To me this looks like the co. is trying to cover their butt now, is that a new disclaimer?  Someone who has followed this as long as I have, texted me and said they smell a rat. People are bailing and no news is coming out. Paul bought a lousy 300 shares the end of  March and it has dropped $5/share since. Was that an effort to support it and give a good impression or was it something

[cleareye]

I haven't see a change since I bought about a year ago. I have no predictions on stock price but I have not lost confidence in the company. I like their mission, as I understand it, We'll see. cleareye.